John Stamos - Public Service Announcement
A Rational Approach
"Functional Profiling" captures the global nature of laboratory tests that examine cancer cells behavior in real-time. Using our ex vivo analyses (EVA), we make it possible to examine small clusters of cancer cells or microspheroids in their native state and in turn take a snapshot of their behavior in response to drugs and combinations.
As the leader in "functional profiling", Rational Therapeutics serves the needs of pharmaceutical companies that can benefit from the early ex-vivo functional profiling of therapeutic activity of novel agents against various human tumor tissue types. With only 14 percent of cooperative group clinical trials currently leading to meaningful advances (Kumar, A. et al Proc ASCO, abs 6066, 2005), the advantage of directed therapies can hardly be overstated. With the only accurate predictive methodology in human cancer, Rational Therapeutics is positioned as the conduit for validation of new platforms offering attractive joint venture and co-development opportunities
|
©2010 Rational Therapeutics. All rights reserved.